Finance

Lists
Why is MRVI up 3,19%?
Dive Deeper
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
7,44 $
+3,19%
(+0,23) 1D
7,52 $
+1,08% (+0,080)
After hours
Closed: 9 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
7,25 $
High
7,52 $
Low
7,17 $
Mkt. cap
1,93 մլրդ
Avg. vol.
2,91 մլն
Volume
2,31 մլն
52-wk high
9,42 $
52-wk low
2,57 $
EPS
-0,53 $
Beta
0,54
Shares outstanding
148,99 մլն
No. of employees
415
Open
7,25 $
High
7,52 $
Low
7,17 $
Mkt. cap
1,93 մլրդ
Avg. vol.
2,91 մլն
Volume
2,31 մլն
52-wk high
9,42 $
52-wk low
2,57 $
EPS
-0,53 $
Beta
0,54
Shares outstanding
148,99 մլն
No. of employees
415
News stories
From web sources and news partners
About Maravai Lifesciences Holdings Inc
CEO-
Employees415
Founded2014
Headquarters-
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to MRVI in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current 7,44 $
9,00 $ (+20,97%)
Average
7,88 $ (+5,91%)
Lowest
6,50 $ (-12,63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brendan Smith
TD Cowen
Buy
Initiated
9,00 $
+21%
10/05/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
09/15/2026
Unknown Analyst
UBS
Hold
Initiated
8,00 $
+7,5%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
8,00 $
+7,5%
09/09/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
8,00 $
+7,5%
08/11/2026
Evan Stampler
Wells Fargo
Buy
Maintained
6,50 $
-12,6%
08/07/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
6,50 $
-12,6%
08/07/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
08/07/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
05/11/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
6,00 $
-19,4%
05/08/2026
Catherine Ramsey Schulte
Robert W. Baird
Hold
Maintained
3,00 $
-59,7%
02/26/2026
Unknown Analyst
Jefferies
Buy
Reiterated
5,00 $
-32,8%
02/26/2026
Last report
06 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,02 $ / -0,04 $
+54,51%beat
Revenue / Est. (USD)
51,44 մլն / 49,52 մլն
+3,88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
41,63 մլն
49,87 մլն
65,84 մլն
51,44 մլն
Cost of goods sold
35,98 մլն
35,32 մլն
32,14 մլն
30,79 մլն
Cost of revenue
35,98 մլն
35,32 մլն
32,14 մլն
30,79 մլն
Research and development expenses
3,84 մլն
3,79 մլն
3,89 մլն
3,70 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35,40 մլն
30,38 մլն
29,09 մլն
32,07 մլն
Operating expense
39,24 մլն
34,17 մլն
32,98 մլն
35,77 մլն
Total operating expenses
75,22 մլն
69,50 մլն
65,12 մլն
66,56 մլն
Operating income
-33,58 մլն
-19,63 մլն
720,00 հզր
-15,12 մլն
Other non operating income
-71,00 հզր
-43,00 հզր
-494,00 հզր
-52,00 հզր
EBT including unusual items
-45,15 մլն
-63,01 մլն
-6,53 մլն
-21,80 մլն
EBT excluding unusual items
-37,70 մլն
-23,84 մլն
-3,65 մլն
-18,82 մլն
Income tax expense
-92,00 հզր
6,00 հզր
-151,00 հզր
-171,00 հզր
Effective tax rate
0,20%
-0,01%
2,31%
0,78%
Other operating expenses
-
-
-
-
Net income
-25,56 մլն
-35,68 մլն
-3,73 մլն
-12,42 մլն
Net profit margin
-61,39%
-71,55%
-5,67%
-24,14%
Earnings per share
-0,08
-0,04
0,01
-0,02
Interest and investment income
2,80 մլն
2,38 մլն
1,87 մլն
1,16 մլն
Interest expense
-6,84 մլն
-6,56 մլն
-5,75 մլն
-4,81 մլն
Net interest expenses
-4,05 մլն
-4,17 մլն
-3,88 մլն
-3,65 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,40 մլն
-7,18 մլն
12,09 մլն
-3,34 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps